Book Value per Share: Boundless Bio Inc. (BOLD)

Graphic logo of Boundless Bio, Inc. (BOLD)

The book value per share curve confirms the demand potential for aggressive cancer therapy for Boundless Bio, Inc. (BOLD). Growth is supported by AI platforms for genome analysis in robotic laboratories and the monetization of patents combating extrachromosomal DNA through partnerships with pharma behemoths. This current trend is justified by these innovations, and 2.91 captures the current state of the parameter, reflecting the real net asset value of Boundless Bio, Inc. (BOLD).

Boundless Bio, Inc (BOLD) Equity per Share: for the period 03/29/2024 - 10/27/2026

Summary analytical data breakdowns for boundlessbio.com (BOLD)

- price and consensus price forecast:
Price Chart Boundless Bio, Inc|BOLD - Price Target Chart
- market capitalization data:
Market Capitalization Boundless Bio, Inc.|BOLD - Business Value
- book capitalization data:
Book Value per Share Boundless Bio|BOLD - Accounting Capitalization|Market Value to Book Value Ratio boundlessbio.com|BOLD - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Boundless Bio, Inc.|BOLD - Long-Term Debt to Capital|Short-Term Debt to Capital Boundless Bio|BOLD - Company Debts|Debt to Book Capitalization Ratio Boundless Bio, Inc.
Fundamental company valuation:Boundless Bio, Inc, BOLD
Manufactured products of boundlessbio.com

Boundless Bio, Inc. (BOLD) minimizes capital expenditures by outsourcing production and testing to third-party contractors to concentrate resources on cancer therapy. This metric calculates the share of net assets per security, allowing for an assessment of the real value of capital excluding market noise, which, combined with GURU.Markets analytics via book value per share dynamics, helps identify business undervaluation or stagnation.

Competitor analysis

TEM - Net Assets per Single Share|QGEN - Net Assets per Single Share|Book Value per Share Ionis Pharmaceuticals|repligen.com (RGEN) - Equity per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|TWST - Book Value per Share|TXG: Net Assets per Single Share|Net Assets per Single Share NTLA|Net Asset Value per Share Stoke Corp|BLFS (BioLife Solutions, Inc.) - Accounting Value per Share|Book Value per Share WVE|Net Assets per Single Share Maze Therapeutics MAZE|Equity per Share Sionna Therapeutics, Inc. (SION)|PRME - Book Value per Share|Taysha Corp - Equity per Share|QURE - Net Assets per Single Share|MGTX - Net Assets per Single Share|Book Value per Share RGNX|SLDB (Solid Biosciences Inc) - Net Asset Value per Share|OCGN: Net Assets per Single Share|Net Assets per Share PACB|BNTC (Benitec Biopharma Inc.) - Net Assets per Single Share|Net Assets per Share designtx.com DSGN|Accounting Value per Share Rocket Pharmaceuticals, Inc.|Accounting Value of a Share 4DMT FDMT|LXEO - Book Value per Share|KRRO - Net Assets per Single Share|Editas Medicine, Inc. - Book Value per Share|SLN (silence-therapeutics.com) - Net Assets per Share|Net Assets per Single Share PRQR (ProQR)|Net Asset Value per Share Codexis Bio (CDXS)|Sangamo (SGMO) - Accounting Value per Share|Accounting Value of a Share nautilus.bio (NAUT)|Book Value per Share MGX|Precision BioSciences Inc. - Net Assets per Share|Generation Bio Corp (GBIO) - Net Assets per Single Share|XCUR - Equity per Share|IMNN (imunon.com) - Book Value per Share|Accounting Value per Share Phio Pharmaceuticals Corp.|MBIO: Accounting Value per Share|Net Assets per Share TransCode|Book Value per Share Bionano Genomics, Inc. (BNGO)|Net Assets per Single Share APDN (Applied DNA Sciences Inc)|BLUE: Net Assets per Single Share|ImmunoPrecise Antibodies Ltd - Net Asset Value per Share|OMGA - Net Assets per Single Share|OMIC - Net Assets per Single Share|Book Value per Share Regulus Therapeutics Inc.|Syros Pharmaceuticals Inc. (SYRS) - Equity per Share|Book Value per Share Codex DNA (TBIO)|Equity per Share TCON|Net Assets per Single Share Unity Biotechnology UBX